South Nassau Communities Hospital in Oceanside on Long
Island, near New York City, said patients may have received
insulin from a pen reservoir — not a single-use disposable
needle — that could have been used on more than one patient.
"The risk of infection from this is extremely low," the hospital
said in a statement, adding it was recommending patients "be
tested for hepatitis B, hepatitis C and HIV."
When asked if anyone was confirmed to have been infected a
hospital spokeswoman said "not to my knowledge."
The pen-shaped insulin injector devices are often used by
hospitals to give the hormone to patients and contain a
reservoir or cartridge, the Centers for Disease Control and
The pens should be limited to one patient because regurgitation
of blood into the insulin cartridge can occur after injection,
creating a risk of blood-borne pathogen transmission, even when
the needle is changed, according to the CDC.
Some 200 of the more than 4,000 patients who were warned have
signed up for free blood testing, WABC-TV reported.
The hospital seems to have changed its policy on the devices,
though it was unclear when the change occurred.
"South Nassau has already implemented a hospital-wide policy
that bans the use of insulin pens and permits only the use of
single-patient-use vials to administer prescribed insulin
treatments to patients," the statement said.
HIV can lead to AIDS, or the acquired immunodeficiency syndrome,
and hepatitis refers to a group of viral infections that affect
the liver, according to the CDC.
(Reporting by Eric M. Johnson and Elizabeth Daley;
[© 2014 Thomson Reuters. All rights
Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.